BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8382999)

  • 41. Regressing atypical histiocytosis, a regressing cutaneous phase of Ki-1-positive anaplastic large cell lymphoma. Immunocytochemical, nucleic acid, and cytogenetic studies of a new case in view of current opinion.
    Motley RJ; Jasani B; Ford AM; Poynton CH; Calonje-Daly JE; Holt PJ
    Cancer; 1992 Jul; 70(2):476-83. PubMed ID: 1319817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
    Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
    Gordon BG; Weisenburger DD; Warkentin PI; Anderson J; Sanger WG; Bast M; Gnarra D; Vose JM; Bierman PJ; Armitage JO
    Cancer; 1993 Jan; 71(1):257-63. PubMed ID: 8380117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
    Shulman LN; Frisard B; Antin JH; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
    J Clin Oncol; 1993 May; 11(5):937-42. PubMed ID: 8387578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.
    Greer JP; Kinney MC; Collins RD; Salhany KE; Wolff SN; Hainsworth JD; Flexner JM; Stein RS
    J Clin Oncol; 1991 Apr; 9(4):539-47. PubMed ID: 1648596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child.
    Gould JW; Eppes RB; Gilliam AC; Goldstein JA; Mikkola DL; Zaim MT; Wood GS
    Am J Dermatopathol; 2000 Oct; 22(5):422-8. PubMed ID: 11048978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
    Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
    J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems.
    Tan SH; Sim CS; Ong BH
    Br J Dermatol; 2003 Sep; 149(3):542-53. PubMed ID: 14510987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas.
    Ribereau-Gayon E; Donzel M; Pham F; Romain-Scelle N; Perier-Muzet M; Balme B; Traverse-Glehen A; Ghesquières H; Dalle S
    Leuk Lymphoma; 2023; 64(8):1424-1432. PubMed ID: 37255021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases.
    Natkunam Y; Warnke RA; Haghighi B; Su LD; Le Boit PE; Kim YH; Kohler S
    J Cutan Pathol; 2000 Sep; 27(8):392-9. PubMed ID: 10955685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary cutaneous CD30+ large-cell lymphoma presenting as a scrotal plaque.
    Modi S; Yang DJ; Sule N; Rosen T
    Dermatol Online J; 2009 Dec; 15(12):9. PubMed ID: 20040259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of adult T-cell leukemia/lymphoma, histologically presenting CD30-positive large cell lymphoma.
    Tsuji M; Kobashi A; Hashimoto K; Tako H; Ikeda H; Fukushima Y; Terada N
    Acta Pathol Jpn; 1992 Jul; 42(7):512-7. PubMed ID: 1357917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
    de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
    Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
    Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.